Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.
Courtesy of Molecular Biometrics
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Company: Molecular Biometrics
Subscribe to Continue Reading
Uh oh–you've read all five of your free articles for this month.
Insider Online Only
$19.95/yr US PRICE
Despite the Hype Over Gene Therapy, Few Drugs Are Close to Approval
There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
How Los Alamos Is Learning to Track Disease Outbreaks Around the World
Nobody agrees on how best to collect data about diseases that threaten human health. That looks set to change.
A Three-Parent Child Was Born in Mexico, Because the U.S. Won’t Allow It
Fertility doctors used a controversial technique to create a single egg from two women’s DNA, fertilized it, and watched as it grew into a healthy baby.